Treatment access

Joint statement by 14 NGOs dismisses TRIPS deal as a ‘gift bound in red tape’

An activist’s view from the WTO meeting in Cancun

South African cabinet rules that public hospitals should provide ARVs

Indian government taken to court over lack of treatment

Township project is a model for care in resource poor settings

Projects band together to buy lowest-cost generic drugs

Facial fat loss – measuring and treatment

Appointment of industry executive to supervise US AIDS initiative provokes criticism

Activist anger over US ‘ambush’ of the Global Fund

$15 billion AIDS bill signed, but full funding shaky

New GAA report: US and G8 must act fast to rescue Global Fund

World Health Assembly approves resolution supporting public health considerations in drug policy

WHO Assembly analysis

Bill Gates to give $1 million to Brazil’s AIDS programme

Adherence is not a barrier to successful antiretroviral therapy in South Africa

The impact of migration, race and ethnic diversity on healthcare delivery and clinical outcomes in the UK

Global Fund requires ‘significant’ new money

Commentary: a crisis the Board must confront

‘Fund the Fund’ launches campaign pack

Senate approves Bush’s $15 billion international AIDS bill

GSK halves drug prices to 63 countries

Shareholders target PepsiCo over care for its employees in Africa

Burkina Faso to purchase generic drugs from Indian company

South Africa fails to accept $41 million from Global Fund

UK gives £15.7m to Burmese HIV project

Death of South African AIDS activist fuels anger

The City turns up the heat on drug companies to make treatment available in poorest countries

Lancet commentary concludes that prevention and treatment in South Africa are affordable and desirable

South Africa treatment protests go global

Gilead to sell tenofovir at cost to 68 countries

New advocacy coalition demands emergency funding from rich governments for Global Fund

NIH/NIAID study of generic drugs shows results consistent with stringent manufacturing standards

Global Fund gives $210 million for treatment in Thailand

Anti-HIV combination drug for Indonesia

Indian generic drug maker Ranbaxy Laboratories to launch own-brand abacavir

Bush blocks deal allowing cheap drugs

Roche to sell nelfinavir, saquinavir at cost to least-developed nations

South Africa appoints another dissident

Bush plans $15 billion budget to treat two million people and prevent seven million infections in 14 countries – but meets criticism from activists

The World Health Organisation must continue its work on access to medicines in developing countries

Dr Jong-Wook Lee nominated to be WHO director-general

AAI Pharma access programme providing treatment for 36,000 people in Africa

Pharmacia to launch pilot programme for expanding access to medicines in the poorest countries

Heineken to offer antirerotviral drug coverage to African workforce

Five pharmaceutical companies to halve antiretroviral drug prices for central America

Patent law overrides would not expand access to drugs for low-income nations, opinion piece says

Combination of three generic drugs in one pill meets bioequivalence criteria when compared with the branded drugs: Triomune vs d4T/3TC/NVP

Lancet special report examines direction new WHO director general should take on several HIV/AIDS-related issues

Europe steps in to protect discounted drugs for developing countries

Profiteers undermine preferential pricing and make millions diverting cheap drugs sent to Africa

Activists win court battle in campaign for generic production of ddI

Global AIDS fund facing bankruptcy

Excitement over anticipated approval of T-20 is balanced by fears that it will be the most expensive HIV drug yet

GlaxoSmithKline cuts drug prices to 63 countries

Bill Clinton and Nelson Mandela promise to lead peer education among political leaders as world looks for $10 billion a year to fight HIV/AIDS

South African activist unveils campaign to force compulsory licences

MSF study shows treatment in resource-poor settings is effective

‘Barcelona Declaration’ demands 2m poor people are treated in the next two years

Lives were lost as experts argued the merits of care versus prevention, says Stefano Vella

Peter Piot sets out the global political agenda in the fight against HIV/AIDS

Health should be a right, not a commodity, and medicine must be removed from the World Trade Organisation, argues key speaker

Governments must act to cut drug prices, says Kenya’s health minister

Civil society had to fight for universal access to AIDS drugs in Brazil

Coalitions of local NGOs can effectively demand access to medicines, reports MSF

Involvement of PLWHA is key to improving access to treatments

Post navigation